Cadrenal Therapeutics (CVKD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist

12.960
+1.510+13.19%

Close Dec 18 16:00 ET

21.50MMarket Cap-2.10P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week With Event Participation and Investor/Partner Meetings
BusinesswireDec 18 09:00 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaDec 13 16:06 ET
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
PR NewswireNov 19 09:00 ET
Cadrenal Therapeutics Files to Sell 590K Shares of Common Stock for Holders
TipRanksNov 14 16:11 ET
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Yahoo FinanceNov 12 09:00 ET
Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 11 13:06 ET · Ratings

Comments

Stock_Drift

Sep 23 15:48

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 17 17:23

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 13 14:27

$Cadrenal Therapeutics (CVKD.US)$

Jaguar8

Aug 20 08:42

NEWS

$Cadrenal Therapeutics (CVKD.US)$
Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
Cadrenal Therapeutics (Nasdaq: CVKD) highlighted a recently published manuscript in the Journal of Cardiac Failure, evaluating the relationship between time in therapeutic range (TTR) management quality and clinical outcomes for left ventricular assist device (LVAD) patients. The findings emphasize the need for improved anticoagulation th...